Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpresaria Group Regulatory News (EMR)

Share Price Information for Empresaria Group (EMR)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.00 (0.00%)
Bid:
21.00
Ask:
24.00
Spread: 3.00 (14.286%)
Market Cap: £11.04m
EMR Live PriceLast checked at - London Stock Exchange

Intraday Empresaria Group Share Chart

Trading Update

26 Oct 2021 07:00

RNS Number : 2008Q
Empresaria Group PLC
26 October 2021
 

26 October 2021

 

Empresaria Group plc

("Empresaria" or the "Group")

 

Trading update

 

Continued growth in profit forecast with Offshore Recruitment Services a key contributor

 

Empresaria, the global specialist staffing group, provides the market with an update on trading for the current financial year ending 31 December 2021.

 

Trading update

 

Following the progress made in the first half of 2021, we have seen increased momentum into the second half of the year as the Group continues to realise the benefits from operational initiatives and the improved economic environment. As a result, it is anticipated that the Group's full year net fee income will be in the range of £57m to £59m and adjusted profit before tax is expected to be in the range of £7.4m to £7.9m (9% to 16% above market consensus).

 

Our Offshore Recruitment Services sector continues to go from strength to strength and delivered a record increase in billable headcount in September. This sector remains core to our future plans through both its external and internal delivery.

 

Our Professional sector has performed better than expected in the third quarter with a strong recovery in our UK hospitality operations and solid performances in Asia despite the very significant levels of local lockdowns. However, the challenges in the aviation industry continue and this is expected to impact us until the sector recovers.

 

Our Healthcare sector has had a very strong 2021. While we were anticipating a significant slowdown in the vaccination programmes in our Healthcare sector in the second half of the year, the autumn COVID-19 booster vaccinations in the US have led to additional demand. This will likely last through to early 2022 after which we expect reduced demand from the vaccination programme.

 

Chief Executive Officer, Rhona Driggs, commented:

 

"I am pleased we are able to deliver this positive news on our trading. Demand continues to be strong across the staffing industry and we are seeing this reflected in most of our businesses. With skills shortages at a 15-year high, candidate attraction and engagement remain a key priority as we close out the year. We are continuing to invest in the future of the business, including the recent appointment of regional leaders who will be instrumental in helping us deliver on our growth strategies. I am pleased to see the positive momentum within the business, and I am confident that we can take advantage of the continued economic recovery to deliver long-term growth."

 

- Ends -

 

Enquiries:

Empresaria Group plcRhona Driggs, Chief Executive OfficerTim Anderson, Chief Financial Officer

via Alma PR

Singer Capital Markets (Nominated Adviser and Broker)Shaun Dobson / James Moat

020 7496 3000

Alma PR (Financial PR)Sam Modlin

David Ison

Hilary Buchanan

020 3405 0205empresaria@almapr.com

 

Notes for editors:

§ Empresaria Group plc is a global specialist staffing group offering temporary and contract recruitment, permanent recruitment and offshore recruitment services across 6 sectors: Professional; IT; Healthcare; Property, Construction and Engineering; Commercial and Offshore Recruitment Services.

 

§ Empresaria operates from locations across the world including the 4 largest staffing markets of the US, Japan, UK and Germany along with a strong presence elsewhere in Asia Pacific and Latin America.

 

§ Empresaria is listed on AIM under ticker EMR. For more information visit empresaria.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKELFLFBLZFBB
Date   Source Headline
7th Sep 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSPDMR Dealing, Exercise of Share Options
22nd Aug 20237:00 amRNSInterim Results
15th Aug 20237:00 amRNSLaunch of LMA Recruitment in the US
27th Jul 20237:00 amRNSTrading Update and Notice of Results
19th Jun 20238:20 amRNSTransaction in Own Shares
6th Jun 20237:00 amRNSTransaction in Own Shares
23rd May 20231:18 pmRNSResult of AGM
23rd May 20237:00 amRNSTrading Update
16th May 20237:00 amRNSTransaction in Own Shares
2nd May 20236:25 pmRNSDirector/PDMR Shareholding
2nd May 20234:26 pmRNSTransaction in Own Shares
28th Apr 20233:50 pmRNSPDMR Dealing, Exercise of Share Options
26th Apr 20237:00 amRNSCompany LTIP Awards
20th Apr 20237:00 amRNSAnnual Report and Accounts and Notice of AGM
30th Mar 202310:15 amRNSTransaction in Own Shares
28th Mar 20237:00 amRNSFinal Results
20th Mar 20233:05 pmRNSNotice of Investor Presentation
20th Feb 20237:00 amRNSAppointment of Independent Non-Executive Director
26th Jan 20237:00 amRNSTrading Update
16th Jan 20237:00 amRNSAppointment of Independent Non-Executive Director
15th Dec 20222:49 pmRNSTransaction in Own Shares
14th Dec 20227:00 amRNSTransaction in Own Shares
12th Dec 20227:18 amRNSTransaction in Own Shares
7th Dec 20228:34 amRNSTransaction in Own Shares
2nd Dec 20227:00 amRNSTransaction in Own Shares
29th Nov 20227:00 amRNSAppointment of Joint Broker
9th Nov 20228:24 amRNSTransaction in Own Shares
4th Nov 20227:00 amRNSTransaction in Own Shares
24th Oct 20227:00 amRNSDirector/PDMR Shareholding
14th Oct 20223:25 pmRNSDirector/PDMR Shareholding
13th Oct 20227:00 amRNSCapital Markets Day
6th Oct 20225:10 pmRNSTransaction in Own Shares
4th Oct 20228:13 amRNSTransaction in Own Shares
1st Sep 202212:23 pmRNSTransaction in Own Shares
12th Aug 20227:00 amRNSTransaction in Own Shares
11th Aug 20227:00 amRNSInterim Results
28th Jul 20227:00 amRNSTrading Update and Notice of Results
20th Jun 202210:54 amRNSTransaction in Own Shares
14th Jun 20229:16 amRNSTransaction in Own Shares
7th Jun 202211:44 amRNSDirector/PDMR Shareholding
7th Jun 202211:37 amRNSTransaction in Own Shares
6th Jun 20227:00 amRNSBoard Update
18th May 20221:40 pmRNSTransaction in Own Shares
17th May 20228:33 amRNSTransaction in Own Shares
12th May 20224:11 pmRNSResult of AGM
12th May 20223:20 pmRNSTransaction in Own Shares
12th May 20227:00 amRNSTrading Update
11th May 20225:09 pmRNSTransaction in Own Shares
10th May 20222:21 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.